DTx Company Hi Signs Supply Contract for Mental Health App 'Maeumjeongwon' with LG Household & Health Care

Digital therapeutics (DTx) specialist company Hi announced on the 15th that it has signed a service supply contract for the mental health recovery application service ‘Maeumjeongwon’ with LG Household & Health Care.

Hai's Mental Health Application Service 'Maeumjeongwon 3.0'
[Photo by Hai]

Through this contract, Hi will provide the mental health app service ‘Maeumjeongwon 3.0’ to LG Household & Health Care. Maeumjeongwon is a service based on the generalized anxiety disorder DTx Anzeilax, which is currently undergoing clinical trials after receiving Investigational New Drug (IND) approval from the Ministry of Food and Drug Safety. It aims to accurately measure users’ stress levels through digital biomarkers and provide customized solutions according to the users’ emotional states, thereby helping users develop the ability to cope with internal and external stress on their own.

Starting this month, the two companies will offer the Maeumjeongwon service to LG Household & Health Care employees who wish to use it. Based on the results of this year’s usage, they also plan to discuss expanding the service to all subsidiaries within LG Household & Health Care in the future.

Kim Jin-woo, CEO of Hi, said, “Based on the capabilities accumulated through over three years of research and various pilot projects, we are introducing the Maeumjeongwon 3.0 service to multiple companies and organizations,” adding, “Starting with LG Household & Health Care, we will continue to secure contracts with companies currently in negotiation.”

This content was produced with the assistance of AI translation services.